Brief: Adaptive Biotechnologies Q2 EPS USD -0.33
02/08/2023 21:06
Aug 02 (Reuters) - Adaptive Biotechnologies Q2 revenue USD 48.926 million vs. IBES estimate USD 44.9 million. * Q2 operating expenses USD 96.744 million * Q2 operating income USD -47.818 million * Q2 net income USD -47.811 million * Q2 adjusted EBITDA USD -24.8 million * Outlook FY Revenue USD 205-215 Million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates